FDANovember 9, 2022drug

Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.

What to do

FDA enforcement status: Terminated

Brands named

imprimisrx njimprimisrx

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →